Radiation 'Bullet' added to standard drug in major prostate cancer fight
NCT ID NCT02194842
Summary
This large, late-stage trial is testing if combining a standard hormone-blocking pill (enzalutamide) with a bone-targeted radiation treatment (Ra223) works better than the pill alone for men whose prostate cancer has spread to their bones and is no longer responding to standard hormone therapy. The main goal is to see if the combination can keep the cancer from getting worse for a longer time, delay bone pain, and help patients live longer. It is for men with few or no symptoms from their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Groeninge Kortrijk
Kortrijk, Belgium
-
AZ Turnhout
Turnhout, Belgium
-
Assistance Publique - Hopitaux de Paris - CHU Henri Mondor
Créteil, 94000, France
-
CHU Dinant Godinne - UCL Namur
Yvoir, 5530, Belgium
-
CHUM - Centre Hospitalier de l'Université de Montreal - Pavillon Saint-Luc
Montreal, Quebec, H2X 3J4, Canada
-
Centre Francois Baclesse
Caen, 14076, France
-
Centre Leon Berard
Lyon, 69008, France
-
Centre de sante et de services sociaux de Chicoutimi
Chicoutimi, Quebec, G7H 5H6, Canada
-
Centro Pesquisas Oncologicas
Florianópolis, 88034000, Brazil
-
Centro de Estudos e Pesquisa Hematologia e Oncologia
Santo André, 09060-650, Brazil
-
Centro de Pesquisas Clinicas em Oncologia - Hospital Sao Lucas
Porto Alegre, 90610 000, Brazil
-
Centro de Tratamentos de Tumores Botafogo
Rio de Janeiro, 22250-040, Brazil
-
Chuq-Pavillon Hotel-Dieu De Quebec
Québec, Quebec, G1R 2J6, Canada
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
-
Clínica Oncológica - CLION
Salvador, 41810-570, Brazil
-
Complejo Hospitalario de Navarra
Pamplona, 31008, Spain
-
Cork University Hospital
Cork, TI2DC4A, Ireland
-
Corporacio Sanitaria Parc Tauli
Sabadell, Spain
-
Gustave Roussy
Villejuif, 94805, France
-
Hamilton And District Urology Association
Hamilton, Ontario, L8N 1T8, Canada
-
Hopital Universitaire Brugmann
Brussels, 1020, Belgium
-
Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme
Brussels, 1070, Belgium
-
Hopitaux Universitaires de Strasbourg - Hôpitaux Universitaires de Strasbourg - Hôpital civil
Strasbourg, 67091, France
-
Hospital Beneficencia Portuguesa
São Paulo, 01321-000, Brazil
-
Hospital Clinic Universitari de Barcelona
Barcelona, 08036, Spain
-
Hospital De La Santa Creu I Sant Pau
Barcelona, 08041, Spain
-
Hospital Del Mar
Barcelona, 08003, Spain
-
Hospital Erasto Gaertner
Curitiba, 81520-060, Brazil
-
Hospital Moinhos de Vento
Porto Alegre, 90035-001, Brazil
-
Hospital Paulistano
São Paulo, 01321-001, Brazil
-
Hospital Universitario QuironSalud
Madrid, 28223, Spain
-
Hospital Universitario Ramon y Cajal
Madrid, 28034, Spain
-
Hospital Universitario de La Princesa
Madrid, 28006, Spain
-
Hospital Universitario de Salamanca
Salamanca, 37007, Spain
-
Hospital de Amor
Barretos, 14.784-400, Brazil
-
Institut de Cancerologie de l'Ouest (ICO) - Centre Paul Papin
Angers, 49055, France
-
Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau
Saint-Herblain, 44805, France
-
Institut régional du Cancer Montpellier
Montpellier, 34298, France
-
Instituto de Medicina Integral Professor Fernando Figueira - IMIP
Recife, 50070-550, Brazil
-
Istituto Europeo di Oncologia
Milan, Italy
-
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Meldola, Italy
-
Kantonsspital St Gallen
Sankt Gallen, Switzerland
-
London Regional Cancer Center
London, Ontario, N6A 4L6, Canada
-
Maria Sklodowska-Curie Memorial Cancer Centre
Warsaw, Poland
-
Nottingham University Hospitals NHS Trust - City Hospital
Nottingham, United Kingdom
-
Odette Cancer Centre - Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
-
Oncocentro
Fortaleza, 60130-241, Brazil
-
Oncology Institute of Southern Switzerland - Ospedale San Giovanni
Bellinzona, 6500, Switzerland
-
Ospedale B.Ramazzini
Carpi, 41012, Italy
-
Rigshospitalet
Copenhagen, Denmark
-
Royal Marsden Hospital - Chelsea, London
London, SW3 6JJ, United Kingdom
-
Saint John Regional Hospital
Saint John, New Brunswick, E2L 4, Canada
-
Sao Camilo Oncologia - Instituto Brasileiro de Controle do Cancer
São Paulo, 03.102-002, Brazil
-
Soerlandet Sykehus-Kristiansand
Kristiansand, 4604, Norway
-
St. Vincent's University Hospital
Dublin, Ireland
-
Tallaght University Hospital
Dublin, Ireland
-
The Christie NHS Foundation Trust
Manchester, United Kingdom
-
U.Z. Leuven - Campus Gasthuisberg
Leuven, 3000, Belgium
-
United Lincolnshire Hospitals NHS Trust - Lincoln County Hospital
Lincoln, LN2 5QY, United Kingdom
-
UniversitaetsSpital Zurich
Zurich, 8091, Switzerland
-
Universitair Ziekenhuis Antwerpen
Edegem, 2650, Belgium
-
University Health Network - Oci Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
-
University Hospital of North Norway
Tromsø, N-9038, Norway
-
Vall d'Hebron Institut d'Oncologia
Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.